The Reflux Company Announces Manufacturing Partnership with Nissha Medical Technologies for Stretta® Relaunch
The Reflux Company is pleased to announce a manufacturing partnership with Nissha Medical Technologies in support of the upcoming relaunch of the Stretta® procedure. This milestone marks a significant step forward in our mission to restore patient access to one of the most clinically validated minimally invasive treatments for gastroesophageal reflux disease (GERD).
About Stretta®
Stretta is a minimally invasive, endoscopic procedure that uses radiofrequency energy to strengthen the tissue of the lower esophageal sphincter — the valve between the esophagus and stomach — reducing reflux that causes chronic GERD symptoms. The procedure requires no incisions, no implants, and no permanent alteration of anatomy, making it a compelling option for patients seeking an alternative to long-term medication or more invasive surgical intervention.
Demand for Stretta has remained strong, both among clinicians and patients. The Reflux Company was founded to provide “patient-centered reflux solutions” with the return of Stretta a cornerstone of that mission.
A Manufacturing Partner Built for Precision
Nissha Medical Technologies is a global leader in the design and contract manufacturing of single-use medical devices, with particular expertise in minimally invasive surgical instruments. Headquartered in Buffalo, New York, and operating across a worldwide network of production and innovation centers, Nissha brings decades of experience, rigorous quality standards, and proven manufacturing capabilities to the Stretta production program.
This partnership reflects our commitment to delivering a product that meets the highest standards of quality, reliability, and regulatory compliance — as physicians and patients have every right to expect.
Looking Ahead
With manufacturing now underway, The Reflux Company is on track for a January 2027 release. We invite physicians and healthcare facilities interested in offering Stretta to their patients to join our waitlist and be among the first to receive product information, pricing, and ordering details.
We are grateful for the continued interest and support of the gastroenterology and surgical community and look forward to sharing further updates as we approach our launch date.
Please visit refluxcompany.com and follow The Reflux Company on Linkedin.
